Contact Person : James Prudhomme; Last Date for the submission of abstract : Not Available ; Description : This year, CHI expanded the scope of the summit to include four concurrent conferences on developing biological drugs with greater safety and efficacy profiles, reduced immunogenicity and a clear regulatory pathway.